Register entry

Tonix Medicines, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
13
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
solution1
spray1
tablet, orally disintegrating1
RouteNDCs
nasal1
subcutaneous1
sublingual1
Labeller name on the listingNDCs
tonix medicines, inc.3
Exclusivity

Patents and exclusivities

13
PatentProductCoversExpiry
10603305TOSYMRAsumatriptanproductJun 2030
11337962TOSYMRAsumatriptanproductJun 2030
12090139TOSYMRAsumatriptanproductJun 2030
9610280TOSYMRAsumatriptanproductJun 2030
9974770TOSYMRAsumatriptanproductJun 2030
9211282TOSYMRAsumatriptanproductJul 2031
10117936TONMYAcyclobenzaprine hydrochlorideproductMar 2034
10864175TONMYAcyclobenzaprine hydrochlorideproductMar 2034
9636408TONMYAcyclobenzaprine hydrochlorideproductMar 2034
9956188TONMYAcyclobenzaprine hydrochlorideproductMar 2034
10537554ZEMBRACE SYMTOUCHsumatriptan succinateuseJan 2036
11364224ZEMBRACE SYMTOUCHsumatriptan succinateuseJan 2036
12097183ZEMBRACE SYMTOUCHsumatriptan succinateproductJan 2036
ProductExclusivityUntil
TONMYACYCLOBENZAPRINE HYDROCHLORIDENP New productAug 2028
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
TONMYACyclobenzaprine Hydrochloridetablet, orally disintegrating, sublingual70792-102NDA
TosymraSumatriptanspray, nasal70792-812NDA
Zembrace SymTouchSumatriptan Succinatesolution, subcutaneous70792-809NDA
Compare

Other companies listing cyclobenzaprine hydrochloride

Enquiry

Common questions

Is Tonix Medicines, Inc. FDA approved?
Tonix Medicines, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Tonix Medicines, Inc. make?
3 products are listed under Tonix Medicines, Inc. in the openFDA NDC Directory, most often as solution; spray; tablet, orally disintegrating. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.